Colton Groome Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$338K Buy
11,856
+2
+0% +$53 0.08% 114
2026
Q2
$285K Sell
11,854
-13
-0.1% -$340 0.07% 138
2026
Q1
$333K Hold
11,867
– – 0.09% 103
2025
Q4
$295K Hold
11,867
– – 0.08% 113
2025
Q3
$302K Hold
11,867
– – 0.09% 110
2025
Q2
$288K Hold
11,867
– – 0.1% 108
2025
Q1
$290K Hold
11,867
– – 0.11% 97
2024
Q4
$315K Sell
11,867
-521
-4% -$14.1K 0.12% 94
2024
Q3
$359K Buy
12,388
+5
+0% +$146 0.13% 96
2024
Q2
$346K Buy
+12,383
New +$341K 0.14% 89
2022
Q1
– Sell
-18,185
Closed -$1.07M – 128
2021
Q4
$1.07M Buy
18,185
+105
+0.6% +$5.2K 0.44% 47
2021
Q3
$778K Hold
18,080
– – 0.34% 50
2021
Q2
$708K Buy
+18,080
New +$703K 0.32% 52

Other funds holding PFE

Colton Groome Financial Advisors's PFE Position: Q3 2026 in Review

Colton Groome Financial Advisors increased its Pfizer (PFE) stake by 0.02% in Q3 2026, buying an estimated $53 and bringing the position to 11,856 shares worth $338K. The position accounts for 0.08% of the portfolio, ranked #114.

Colton Groome Financial Advisors first reported a position in PFE in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.07M in Q4 2021. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Colton Groome Financial Advisors held 11,856 shares of Pfizer worth $338K as of Q3 2026.
  • Colton Groome Financial Advisors bought 2 Pfizer shares in Q3 2026, an estimated $53.
  • Pfizer made up 0.08% of Colton Groome Financial Advisors's portfolio in Q3 2026, its #114 holding.
  • Colton Groome Financial Advisors first reported a position in Pfizer in Q2 2021 and has held it in 13 quarters since.
  • Colton Groome Financial Advisors's Pfizer position peaked at $1.07M in Q4 2021.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Colton Groome Financial Advisors's 13F filing for Q3 2026, filed 6 Oct 2026.